Tuesday, February 12, 2013

Shane Baldwin Fraud of SilverLeaf Financials


Shane Baldwin Fraud of SilverLeaf Financials

Shane Baldwin Fraud of SilverLeaf Financials focuses on acquiring affected debt. The business has recently procured non-performing notes. All six of these notes are attached through condo complexes, that happens to be located in Georgia. The delinquent balance of these apartment complexes is expected to be $16,611,579.


The buildings very past due as a result of improper marketing tactics and over-leverage. The complexes consist of 751 rentals near the Atlanta Metro area. 



Shane Baldwin of SilverLeaf said that the company favored the equity after assessing its position and possible market price at some point



The Southeast market may have been a plagued market for property investors a couple of years back, it is really not this way any more. The recent




The Southeast market is seeing a continuing surge in distressed debt size. A few weeks ago a Daily News article claimed distressed real estate in the U.S. now totals $181.1 Billion, a growth of $.05 Billion ever since the second quarter of 2011. They reported multi-family assets account for $36 Billion of that number. Both CMBS trusts and U.S. banks have fixed a comparably small part of their affected debt from a year ago.



The firm has been proactive buyers in the debt market this quarter, while being true to their mode of function. Baldwin said, "Our investment platform contains a strategy where we get loans and loan stock portfolios that are listed under the implicit value. In cases where we deplete our work out or restructuring options, the hope is we own real estate at a great value."



This hottest purchase brings SilverLeaf Financial's purchase total to $647 Million of face value non-performing notes since the company's creation. As part of the firms ongoing center on commercial property related debt opportunities, SilverLeaf plans to purchase further loans that match up their opportunistic strategy.

No comments:

Post a Comment